Compagnie Lombard Odier SCmA’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14	Closed	-$3K	–	615
2020 Q2	$3K	Hold	14	–	–	﹤0.01%	509
2020 Q1	$2K	Buy	14 +4	+40%	+$529	﹤0.01%	481
2019 Q4	$1K	Hold	10	–	–	﹤0.01%	517
2019 Q3	$1K	Hold	10	–	–	﹤0.01%	523
2019 Q2	$1K	Hold	10	–	–	﹤0.01%	519
2019 Q1	$0	Hold	10	–	–	﹤0.01%	628
2018 Q4	$0	Hold	10	–	–	﹤0.01%	624
2018 Q3	$1K	Hold	10	–	–	﹤0.01%	556
2018 Q2	$1K	Hold	10	–	–	﹤0.01%	592
2018 Q1	$1K	Sell	10 -10	-50%	-$1.49K	﹤0.01%	595
2017 Q4	$14K	Buy	20 +10	+100%	+$3.86K	﹤0.01%	594
2017 Q3	$3K	Hold	10	–	–	﹤0.01%	673
2017 Q2	$3K	Hold	10	–	–	﹤0.01%	690
2017 Q1	$3K	Hold	10	–	–	﹤0.01%	706
2016 Q4	$6K	Hold	10	–	–	﹤0.01%	771
2016 Q3	$11K	Hold	10	–	–	﹤0.01%	836
2016 Q2	$11K	Hold	10	–	–	﹤0.01%	826
2016 Q1	$13K	Hold	10	–	–	﹤0.01%	867
2015 Q4	$25K	Sell	10 -10	-50%	-$15.4K	﹤0.01%	776
2015 Q3	$22K	Hold	20	–	–	﹤0.01%	686
2015 Q2	$20K	Buy	+20	New	+$21.6K	﹤0.01%	720